Methylisopropyllysergamide

From Self-sufficiency
Revision as of 21:19, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): hallucinogen-stub)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Methylisopropyllysergamide
140px
Systematic (IUPAC) name
(8β)- N- isopropyl- N,6- dimethyl- 9,10- didehydroergoline- 8- carboxamide
Identifiers
ATC code none
Synonyms

(6aR,9R)- N-methyl- N-isopropyl- 7-methyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide;

Lysergic acid methylisopropyl amide
Chemical data
Formula C20H25N3O
Molar mass 323.431 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Methylisopropyllysergamide (lysergic acid methylisopropyl amide, MIPLA) is an analogue of LSD that was originally discovered by Albert Hofmann at Sandoz during the original structure-activity research into LSD. It has subsequently been investigated in more detail by the team led by David E. Nichols at Purdue University. Methylisopropyllysergamide is a structural isomer of LSD, with the alkyl groups on the amide nitrogen having been subjected to a methylene shuffle. It is the only simple N,N-dialkyl lysergamide that approaches the potency of LSD itself, being around 1/3rd-1/2 the potency of LSD, while all other dialkyl analogues (dimethyl, dipropyl, methylethyl etc) are only around 1/10th as potent as LSD.[1] Apart from its lower potency, the hallucinogenic effects of methylisopropyllysergamide are similar to those of LSD itself, and the main use for this drug has been in studies of the binding site at the 5-HT2A receptor through which LSD exerts most of its pharmacological effects.[2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Hofmann A. Psychotomimetic Drugs: Chemical and Pharmacological Aspects. Acta. Physiol. Pharmacol. Neerlandica. 1959;8:240-258.
  2. David E. Nichols. LSD and Its Lysergamide Cousins. The Heffter Review of Psychedelic Research. 2001;2:80-87.